Sort   by:  
 Page size 

Purpose

To develop a genomic signature that predicts benefit from trastuzumab in human epidermal growth factor receptor 2-positive breast cancer.

Patients and methods

DASL technology was used to quantify mRNA in samples from 1,282 patients enrolled onto the Combination Chemotherapy Wi...
Sort   by:  
 Page size